ENB Financial Corp Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure
ENB Financial Corp (ENBP) reported Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure of $227.75 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes
us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure · last filed 2021-11-12
- ENB Financial Corp concentration risk, credit risk, financial instrument, maximum exposure for the quarter ending 2021-09-30 was $10.12M, a 51.53% decline year-over-year.
- ENB Financial Corp concentration risk, credit risk, financial instrument, maximum exposure for the quarter ending 2021-06-30 was $8.48M.
- ENB Financial Corp concentration risk, credit risk, financial instrument, maximum exposure for the quarter ending 2021-03-31 was $209.15M.
- ENB Financial Corp concentration risk, credit risk, financial instrument, maximum exposure for the quarter ending 2020-12-31 was -$10.73M.
- ENB Financial Corp concentration risk, credit risk, financial instrument, maximum exposure for fiscal 2020 was $205.22M.
| Period end | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 3 month | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 6 month | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 9 month | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 12 month |
|---|---|---|---|---|
| 2021-09-30 | $10.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $18.60M derived: sum of 2 quarters · filed 2021-11-12 | $227.75M 10-Q · filed 2021-11-12 | $217.02M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $217.63M 10-Q · filed 2021-08-12 | $206.90M derived: sum of 3 quarters · filed 2021-08-12 | $227.78M derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $209.15M 10-Q · filed 2021-05-14 | $198.42M derived: sum of 2 quarters · filed 2021-05-14 | $219.30M derived: sum of 3 quarters · filed 2021-05-14 | |
| 2020-12-31 | -$10.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $10.15M derived: sum of 2 quarters · filed 2021-03-29 | $205.22M 10-K · filed 2021-03-29 | |
| 2020-09-30 | $20.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $215.95M 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | $195.07M 10-Q · filed 2020-08-14 |